256 related articles for article (PubMed ID: 20855461)
1. Orally administered particulate beta-glucan modulates tumor-capturing dendritic cells and improves antitumor T-cell responses in cancer.
Li B; Cai Y; Qi C; Hansen R; Ding C; Mitchell TC; Yan J
Clin Cancer Res; 2010 Nov; 16(21):5153-64. PubMed ID: 20855461
[TBL] [Abstract][Full Text] [Related]
2. Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans.
Qi C; Cai Y; Gunn L; Ding C; Li B; Kloecker G; Qian K; Vasilakos J; Saijo S; Iwakura Y; Yannelli JR; Yan J
Blood; 2011 Jun; 117(25):6825-36. PubMed ID: 21531981
[TBL] [Abstract][Full Text] [Related]
3. β-glucan from Aureobasidium pullulans augments the anti-tumor immune responses through activated tumor-associated dendritic cells.
Shui Y; Hu X; Hirano H; Kusano K; Tsukamoto H; Li M; Hasumi K; Guo WZ; Li XK
Int Immunopharmacol; 2021 Dec; 101(Pt A):108265. PubMed ID: 34715491
[TBL] [Abstract][Full Text] [Related]
4. β-Glucan enhances antitumor immune responses by regulating differentiation and function of monocytic myeloid-derived suppressor cells.
Tian J; Ma J; Ma K; Guo H; Baidoo SE; Zhang Y; Yan J; Lu L; Xu H; Wang S
Eur J Immunol; 2013 May; 43(5):1220-30. PubMed ID: 23424024
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of GITRL on dendritic cells by WGP improves anti-tumor immunity in murine Lewis lung carcinoma.
Tian J; Ma J; Ma K; Ma B; Tang X; Baidoo SE; Tong J; Yan J; Lu L; Xu H; Wang S
PLoS One; 2012; 7(10):e46936. PubMed ID: 23077535
[TBL] [Abstract][Full Text] [Related]
6. Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models.
Hong F; Yan J; Baran JT; Allendorf DJ; Hansen RD; Ostroff GR; Xing PX; Cheung NK; Ross GD
J Immunol; 2004 Jul; 173(2):797-806. PubMed ID: 15240666
[TBL] [Abstract][Full Text] [Related]
7. Soluble β-glucan from Grifola frondosa induces tumor regression in synergy with TLR9 agonist via dendritic cell-mediated immunity.
Masuda Y; Nawa D; Nakayama Y; Konishi M; Nanba H
J Leukoc Biol; 2015 Dec; 98(6):1015-25. PubMed ID: 26297795
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Lewis lung carcinoma by photodynamic therapy and glucan from barley.
Akramiene D; Grazeliene G; Didziapetriene J; Kevelaitis E
Medicina (Kaunas); 2009; 45(6):480-5. PubMed ID: 19605969
[TBL] [Abstract][Full Text] [Related]
9. Yeast beta-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via complement receptor 3-Syk-phosphatidylinositol 3-kinase pathway.
Li B; Allendorf DJ; Hansen R; Marroquin J; Ding C; Cramer DE; Yan J
J Immunol; 2006 Aug; 177(3):1661-9. PubMed ID: 16849475
[TBL] [Abstract][Full Text] [Related]
10. β-Glucan induces autophagy in dendritic cells and influences T-cell differentiation.
Ding J; Ning Y; Bai Y; Xu X; Sun X; Qi C
Med Microbiol Immunol; 2019 Feb; 208(1):39-48. PubMed ID: 30088084
[TBL] [Abstract][Full Text] [Related]
11. The effects of β-glucans on dendritic cells and implications for cancer therapy.
Albeituni SH; Yan J
Anticancer Agents Med Chem; 2013 Jun; 13(5):689-98. PubMed ID: 23092290
[TBL] [Abstract][Full Text] [Related]
12. β-glucan restores tumor-educated dendritic cell maturation to enhance antitumor immune responses.
Ning Y; Xu D; Zhang X; Bai Y; Ding J; Feng T; Wang S; Xu N; Qian K; Wang Y; Qi C
Int J Cancer; 2016 Jun; 138(11):2713-23. PubMed ID: 26773960
[TBL] [Abstract][Full Text] [Related]
13. Oral administration of soluble β-glucans extracted from Grifola frondosa induces systemic antitumor immune response and decreases immunosuppression in tumor-bearing mice.
Masuda Y; Inoue H; Ohta H; Miyake A; Konishi M; Nanba H
Int J Cancer; 2013 Jul; 133(1):108-19. PubMed ID: 23280601
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of various beta-glucan sources in conjunction with anti-tumor monoclonal antibody in cancer therapy.
Driscoll M; Hansen R; Ding C; Cramer DE; Yan J
Cancer Biol Ther; 2009 Feb; 8(3):218-25. PubMed ID: 19106638
[TBL] [Abstract][Full Text] [Related]
15. The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity.
Prins RM; Craft N; Bruhn KW; Khan-Farooqi H; Koya RC; Stripecke R; Miller JF; Liau LM
J Immunol; 2006 Jan; 176(1):157-64. PubMed ID: 16365406
[TBL] [Abstract][Full Text] [Related]
16. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells.
Hong F; Hansen RD; Yan J; Allendorf DJ; Baran JT; Ostroff GR; Ross GD
Cancer Res; 2003 Dec; 63(24):9023-31. PubMed ID: 14695221
[TBL] [Abstract][Full Text] [Related]
17. Consumption of β-glucans to spice up T cell treatment of tumors: a review.
de Graaff P; Govers C; Wichers HJ; Debets R
Expert Opin Biol Ther; 2018 Oct; 18(10):1023-1040. PubMed ID: 30221551
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of mGITRL on D2SC/1 cells by particulate β-glucan impairs the suppressive effect of CD4+CD25+ regulatory T cells and enhances the effector T cell proliferation.
Tian J; Ma J; Wang S; Yan J; Chen J; Tong J; Wu C; Liu Y; Ma B; Mao C; Jiao Z; Shao Q; Lu L; Xu H
Cell Immunol; 2011; 270(2):183-7. PubMed ID: 21636079
[TBL] [Abstract][Full Text] [Related]
19. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
20. Oral beta-glucan adjuvant therapy converts nonprotective Th2 response to protective Th1 cell-mediated immune response in mammary tumor-bearing mice.
Baran J; Allendorf DJ; Hong F; Ross GD
Folia Histochem Cytobiol; 2007; 45(2):107-14. PubMed ID: 17597024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]